Exchange: OTC·Updated 03:45 PM EST

APLIF Appili Therapeutics Inc

$0.001
$0.001
(50.00%)
Today
Mkt Cap$132,400.00
Vol15,207.00

About APLIF

Appili Therapeutics, Inc. is a biopharmaceutical company, which engages in acquisition and development of novel treatments targeting unmet needs in infectious disease. It focuses on building and advancing a diverse portfolio of anti-infective programs such as LIKMEZ, ATI-1701 and ATI-1801. The company was founded on May 7, 2015 and is headquartered in Halifax, Canada.
28

Bearish Sentiment

How do you feel about APLIF?

Advertisement|Remove ads.